VISTAGEN THERAPEUTICS, INC. Other Nonoperating Expense
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Other Nonoperating Expense of $2.30 thousand for the 12-month period ending 2016-03-31, per its 10-K filed 2016-06-24.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2016-06-24
- VISTAGEN THERAPEUTICS, INC. other nonoperating expense for fiscal 2016 was $2.30K, a 98.30% decline from fiscal 2015.
- VISTAGEN THERAPEUTICS, INC. other nonoperating expense for fiscal 2015 was $135.00K.
| Period end | Other Nonoperating Expense 12 month |
|---|---|
| 2016-03-31 | $2.30K 10-K · filed 2016-06-24 |
| 2015-03-31 | $135.00K 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |